Takeda Pharmaceutical fails to declare 122.3 bil. yen in income

OSAKA, Japan - Takeda Pharmaceutical Co. Executive Director Toyoji Yoshida (fore) speaks at a press conference in Osaka on June 28. He said his company failed to declare 122.3 billion yen in taxable income over six years to March 2005.

Sample
PDF Preview

Product Code
ILEA001116843

Registered date
2006/6/28 00:00:00

Credit
Kyodo / Kyodo News Images

Media source
2006 Kyodo News

Media size
1864 × 1228 pixel

Resolution
dpi

Deployment size
428.79(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Dollar surges to 160 yen range

Screens at a foreign exchange trading company in Tokyo show the U.S. dollar trading at the 160.80 yen level on June 27, 2024, after climbing to its highest level in over 37 years on expectations the interest rate differential between Japan and the United States will remain wide.

BYD launches 3rd EV model for Japan

Photo taken on June 25, 2024, shows Chinese electric vehicle maker BYD Co.'s Seal sedan on display at the venue of its press conference in Tokyo to launch the company's third EV model for Japan.

Oracle to invest $8 bil. in Japan

U.S. IT firm Oracle Corp. CEO Safra Catz holds a press conference in Tokyo on April 18, 2024. She said the Japanese unit of Oracle Corp. will invest $8 billion in Japan over the next 10 years to respond to the country's growing demand for cloud computing and artificial intelligence.

Oracle to invest $8 bil. in Japan

Daihatsu unveils new management policy after testing scandal

TOKYO, Japan, April 8 Kyodo - Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business. (Kyodo)

New whaling factory ship

Hideki Tokoro, president of commercial whaling operator Kyodo Senpaku Co., meets the press in Shimonoseki, western Japan, on March 29, 2024, after Kangei Maru, the world's only whaling factory ship, was delivered to his company earlier in the day, following the retirement of its predecessor, Nisshin Maru, in November 2023.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi speaks at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (C) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd from L) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (R) apologizes at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.